Propofol: A Medication That Changed Pediatric Anesthesia Practice
Pediatric Anesthesia · 2025
DOI: 10.1111/pan.70001 ↗At a glance
Übersichtsarbeit in Pediatric Anesthesia, 2025. Written by Brian J Anderson and 1 co-authors. Institution: Department of Anaesthesiology, University of Auckland, Auckland, New Zealand. Major MEDLINE topics: Propofol, Anesthetics, Intravenous, Pediatrics, Anesthesia. Cited 7 times so far (Crossref); 107 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
The introduction of propofol changed our understanding of pediatric anesthesia pharmacology, research approaches for intravenous drug study, and led to infusion pump development for the maintenance phase of anesthesia. The story of propofol development provides a blueprint for other intravenous drug development. The introduction of the target concentration strategy based on pharmacokinetic‐pharmacodynamic and covariate understanding is central to total intravenous anesthesia techniques and is best exemplified by propofol. While use of the EEG to gauge depth of anesthesia preceded the propofol era, processed EEG signals enabled description of the relationship between propofol plasma concentration and effect, advancing propofol use and safety. Clinical need drove the characterization of propofol pharmacokinetics and concentration effect relationships in children. Subsequently, study in populations such as neonates, the critically ill, and children with obesity explored covariate influences. Target‐controlled infusions also required an appreciation of effect site concentrations and time delays, and drug interactions such as those between propofol and opioids. Supraglottic airway use in children paralleled propofol use because greater depression of pharyngeal and laryngeal reactivity was noted with propofol than seen than with thiopental. Environmental concerns with the carbon footprint of inhalational agents may yet see infusions assume dominance for maintenance anesthesia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anaesthesiology, University of Auckland, Auckland, New Zealand.
- División Anestesiología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
ORCID profiles: Brian J Anderson, L Ignacio Cortinez
Cite
APA
Anderson, B. J., & Cortinez, L. I. (2025). Propofol: A Medication That Changed Pediatric Anesthesia Practice. Pediatric Anesthesia. https://doi.org/10.1111/pan.70001
Vancouver
Anderson BJ, Cortinez LI. Propofol: A Medication That Changed Pediatric Anesthesia Practice. Pediatric Anesthesia. 2025. doi:10.1111/pan.70001
BibTeX
@article{Anderson2025,
author = {Anderson, Brian J and Cortinez, L Ignacio},
title = {Propofol: A Medication That Changed Pediatric Anesthesia Practice},
journal = {Pediatric Anesthesia},
year = {2025},
doi = {10.1111/pan.70001}
}
EUVIMED